Parabilis Medicines, Inc. has set a record for the largest biotech initial public offering, with reports varying on the exact amount raised, between $670m and $770.5m. The company's stock price soared 58% on its first day of trading, reaching a market capitalization of $3.7 billion on the NASDAQ. The significant increase has raised questions about whether it is still a good time to buy the stock.